Growth Metrics

Mannkind (MNKD) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 198.34%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14,223.53%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 453.08%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.46%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -2,361.13%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,361.13%
Dec 31, 2025 -227.52%
Sep 30, 2025 305.41%
Jun 30, 2025 110.11%
Mar 31, 2025 102.16%
Dec 31, 2024 -110.31%
Sep 30, 2024 -981.66%
Jun 30, 2024 -30,543.49%
Mar 31, 2024 -380.76%
Dec 31, 2023 905.65%
Sep 30, 2023 -116.85%
Jun 30, 2023 100.99%
Mar 31, 2023 128.28%
Dec 31, 2022 -78.66%
Sep 30, 2022 274.37%
Jun 30, 2022 82.89%
Mar 31, 2022 -131.49%
Dec 31, 2021 401.38%
Sep 30, 2021 0.39%
Jun 30, 2021 -861.55%
Mar 31, 2021 1,917.72%
Dec 31, 2020 5,511.61%
Sep 30, 2020 -162.91%
Jun 30, 2020 211.85%
Mar 31, 2020 124.47%
Dec 31, 2019 -100.44%
Sep 30, 2019 209.29%
Jun 30, 2019 -4,023.67%
Mar 31, 2019 -73.41%
Dec 31, 2018 114.81%
Sep 30, 2018 32.41%
Jun 30, 2018 88.51%
Mar 31, 2018 -184.21%
Dec 31, 2017 323.69%
Sep 30, 2017 17.41%
Jun 30, 2017 -112.73%
Mar 31, 2017 179.83%
Dec 31, 2016 -148.32%
Sep 30, 2016 62.02%
Jun 30, 2016 364.19%
Mar 31, 2016 -1,047,466.67%
Dec 31, 2015 150.65%
Sep 30, 2015 -156.58%
Jun 30, 2015 -350.36%
Mar 31, 2015 100.01%
Dec 31, 2014 -124.33%
Sep 30, 2014 101.08%
Jun 30, 2014 941.03%
Mar 31, 2014 -3.53%
Dec 31, 2013 -138.31%
Sep 30, 2013 318.50%
Jun 30, 2013 102.12%
Mar 31, 2013 -163.04%
Dec 31, 2012 398.81%
Sep 30, 2012 -1,405.75%
Jun 30, 2012 -11.62%
Mar 31, 2012 380.30%
Dec 31, 2011 36.91%
Sep 30, 2011 -102.85%